Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to see if the study drug, FMX-103, is safe to give and if it helps people with moderate-to-severe papulopustular rosacea. The investigational product is FMX-103 minocycline foam. Two concentrations of the investigational product, 1.5% and 3%, will be studied along with vehicle. The foam will be applied once daily to the face for the 12-week treatment duration of the study. Approximately 210 patients will participate in this study.
Epistemonikos ID: 7588e448a621b4be5a707bc10fff78231ad3a9e4
First added on: May 12, 2024